Fecal microbiota transplantation to prevent acute graft-versus-host disease: pre-planned interim analysis of donor effect
TB-500's strengths lie in general tissue regeneration and recovery
Who Should Use This Product: This product is intended for adults who require higher-potency, targeted support for joint health, digestive function, and gut-brain axis balance, particularly when lower gastrointestinal support is needed
available only through 503A compounding pharmacies under physician supervision Typical research dose range / 200-800 mcg/day subcutaneously, cycled 4-8 weeks Known lethal dose (LD50) / Not established in any species studied to date Rodent acute toxicity ceiling / No mortality observed at doses exceeding 10 mg/kg intraperitoneally Most reported excess-dose symptoms / Nausea, lightheadedness, flushing, injection-site irritation Organ toxicity at supratherapeutic doses / Not demonstrated in published preclinical literature Antidote availability / No specific antidote exists
mg/mL mL units Reconstitution math only not dosing advice
These compounds specifically support the livers ability to process and transport fats, which is its primary function